Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766

Comprehensive molecular characterization of human colon and rectal cancer

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067

Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870

The Genomic Landscapes of Human Breast and Colorectal Cancers

Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623

A comprehensive overview of promising biomarkers in stage II colorectal cancer

Parent, P., Cohen, R., Rassy, E., Svrcek, M., Taı̈eb, J., André, T., & Turpin, A. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102059 · Cited by 22

Oncogene Concatenated Enriched Amplicon Nanopore Sequencing for rapid, accurate, and affordable somatic mutation detection

Thirunavukarasu, D., Cheng, L. Y., Song, P., Chen, S. X., Borad, M. J., Kwong, L. N., James, P. L., Turner, D., & Zhang, D. Y. (2021) · Genome biology · doi:10.1186/s13059-021-02449-1 · Cited by 21

Personalizing Therapy for Metastatic Prostate Cancer: The Role of Solid and Liquid Tumor Biopsies

Friedlander, T. W., Pritchard, C. C., & Beltran, H. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175510 · Cited by 21

Liquid biopsy for gastric cancer: Techniques, applications, and future directions

del Arco, C. D., Fernández‐Aceñero, M. J., & Medina, L. O. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i12.1680 · Cited by 24

ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach

Nielsen, L. R., Guldbrandsen, K. F., Ahlborn, L. B., Bloch, M., Skougaard, K., Albrecht‐Beste, E., Nellemann, H. M., Krakauer, M., Gørtz, P. M., Fledelius, J., et al. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108528 · Cited by 21

Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer

Moding, E. J., Esfahani, M. S., Jin, C., Hui, A. B., Nabet, B. Y., Liu, Y., Chabon, J. J., Binkley, M. S., Kurtz, D. M., Hamilton, E. G., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1704 · Cited by 23

Lung metastases

Zullo, L., Filippiadis, D. K., Hendriks, L. E. L., Portik, D., Spicer, J. D., Wistuba, I. I., & Besse, B. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00642-1 · Cited by 23

Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction

Gabriel, E. M., & Bagaria, S. P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00297 · Cited by 22

Radiologic T staging of colon cancer: renewed interest for clinical practice

Chang, K. J., Kim, D. H., Lalani, T., Paroder, V., Pickhardt, P. J., Shaish, H. A., & Bates, ‬. D. B. (2023) · Abdominal Radiology · doi:10.1007/s00261-023-03904-2 · Cited by 21

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights

Yu, J. B., Park, R., & Kim, R. D. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s341195 · Cited by 23

Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients

Frydendahl, A., Nors, J., Rasmussen, M. H., Henriksen, T. V., Nesic, M., Reinert, T., Afterman, D., Lauterman, T., Kuzman, M., Gonzalez, S., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114314 · Cited by 21

Identification of specific modules and significant genes associated with colon cancer by weighted gene co‑expression network analysis

Feng, Y., Li, Y., Li, L., Wang, X., & Chen, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10295 · Cited by 20

Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR

Wood-Bouwens, C. M., Haslem, D. S., Moulton, B., Almeda, A. F., Lee, H., Heestand, G. M., Nadauld, L. D., & Ji, H. P. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.10.008 · Cited by 21

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial

van der Wilk, B. J., Eyck, B. M., Doukas, M., Spaander, M. C. W., Schoon, E. J., Krishnadath, K. K., Oostenbrug, L. E., Lagarde, S. M., Wijnhoven, B. P. L., Looijenga, L. H. J., et al. (2020) · British journal of surgery · doi:10.1002/bjs.11760 · Cited by 21

MIPP-Seq: ultra-sensitive rapid detection and validation of low-frequency mosaic mutations

Doan, R. N., Miller, M. B., Kim, S. N., Rodin, R. E., Ganz, J., Bizzotto, S., Morillo, K. S., Huang, A. Y., Digumarthy, R., Zemmel, Z. M., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00893-3 · Cited by 20

Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer

Sonoda, H., Yamada, T., Matsuda, A., Ohta, R., Shinji, S., Yokoyama, Y., Takahashi, G., Iwai, T., Takeda, K., Ueda, K., et al. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.05.041 · Cited by 20

Cell-free DNA Analysis in Cancer

Corcoran, R. B., & Chabner, B. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1816154 · Cited by 21

Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations

Wilbur, H. C., Soares, H. P., & Azad, N. S. (2024) · Hepatology · doi:10.1097/hep.0000000000000760 · Cited by 21

Performance Comparison of Droplet Digital PCR and Next‐Generation Sequencing for Circulating Tumor DNA Detection in Non‐Metastatic Rectal Cancer

Szeto, S., Kytölä, S. I., Erkan, E. P., Ahtiainen, M., Mecklin, J., Kuopio, T., Sallinen, V. J., Lepistö, A., Koskenvuo, L. E., Renkonen‐Sinisalo, L., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70943 · Cited by 23

Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non‐small cell lung cancer patients

Li, H., Ma, Z., Li, B., Pan, Y., Xiang, J., Zhang, Y., Sun, Y., Hou, T., Lizaso, A., Chen, Y., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4339 · Cited by 20

CtDNA’s prognostic value in patients with early-stage colorectal cancer after surgery: A meta-analysis and systematic review

Fan, X., Zhang, J., & Lu, D. (2023) · Medicine · doi:10.1097/md.0000000000032939 · Cited by 20

Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging

Watanabe, F., Suzuki, K., Aizawa, H., Endo, Y., Takayama, Y., Kakizawa, N., Kato, T., Noda, H., & Rikiyama, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-31051-7 · Cited by 20

Diagnostic Value of Inflammation-Related Indicators in Distinguishing Early Colon Cancer and Adenomatous Polyps

Feng, Z., Lin, H., Yang, X., Cao, S., Gu, X., Zhang, Z., & Deng, W. (2023) · Cancer Control · doi:10.1177/10732748231180745 · Cited by 20

Redefining precision radiotherapy through liquid biopsy

McLaren, D. B., & Aitman, T. J. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02398-5 · Cited by 23

Liquid biopsy in colorectal cancer: Onward and upward

Torresan, S., de Scordilli, M., Bortolot, M., Nardo, P. D., Foltran, L., Fumagalli, A., Guardascione, M., Ongaro, E., & Puglisi, F. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104242 · Cited by 24

Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in glioma

Jones, J., Nguyen, H. P. T., Wong, S. Q., Whittle, J. R., Iaria, J., Stylli, S. S., Towner, J., Pieters, T. A., Gaillard, F., Kaye, A. H., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae027 · Cited by 22

Latest Research Progress of Liquid Biopsy in Tumor—A Narrative Review

Hua, J. (2024) · Cancer Management and Research · doi:10.2147/cmar.s479338 · Cited by 20

Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment

Crisafulli, G. (2025) · Genes · doi:10.3390/genes16010071 · Cited by 20

An integrated multi-molecular sensor for simultaneous BRAF V600E protein and DNA single point mutation detection in circulating tumour cells

Dey, S., Koo, K. M., Wang, Z., Sina, A. A. I., Wuethrich, A., & Trau, M. (2018) · Lab on a Chip · doi:10.1039/c8lc00991k · Cited by 20

Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer

Osumi, H., Shinozaki, E., & Yamaguchi, K. (2020) · Cancers · doi:10.3390/cancers12061566 · Cited by 21

Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care

Haselmann, V., Hedtke, M., & Neumaier, M. (2022) · Diagnostics · doi:10.3390/diagnostics12030748 · Cited by 20

Liquid Biopsy in Gastrointestinal Cancers

Saini, A., Pershad, Y., Albadawi, H., Kuo, M., Alzubaidi, S. J., Naidu, S., Knuttinen, M. G., & Öklü, R. (2018) · Diagnostics · doi:10.3390/diagnostics8040075 · Cited by 20

The mutational landscape of spinal chordomas and their sensitive detection using circulating tumor DNA

Mattox, A. K., Yang, B., Douville, C., Lo, S.-F., Sciubba, D., Wolinsky, J. P., Gokaslan, Z. L., Robison, J., Blair, C., Jiao, Y., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa173 · Cited by 21

Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis

Camblor, D. G., Martínez-Castedo, B., Martín-Arana, J., Gimeno-Valiente, F., García-Micó, B., Martinez, F. M., Seguí, V., García-Bartolomé, M., González, D., Guimera, A., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103066 · Cited by 23

Insights from Large-Scale Cancer Genome Sequencing

Mardis, E. R. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-122035 · Cited by 20

Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy

Lee, S. H., Park, Y. S., Chang, W.-J., Choi, J. Y., Lim, A.-R., Kim, B., Lee, S.-B., Lee, J. W., Kim, S. H., Kim, J., et al. (2021) · Cancers · doi:10.3390/cancers13092231 · Cited by 19

Clonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers

Croitoru, V. M., Cazacu, I. M., Popescu, I., Paul, D., Dima, S., Croitoru, A. E., & Tănase, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.772166 · Cited by 21

Emerging Technologies for the Detection of Cancer Micrometastasis

Mao, X., Mei, R., Yu, S., Shou, L., Zhang, W., Li, K., Qiu, Z., Xie, T., & Sui, X. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221100355 · Cited by 21

Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease—From Early Cancer Detection to Individualized Cancer Treatment

David, P., Mittelstädt, A., Kouhestani, D., Anthuber, A., Kahlert, C., Sohn, K., & Weber, G. F. (2023) · Cancers · doi:10.3390/cancers15071924 · Cited by 18

Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer

Gimeno-Valiente, F., Martín-Arana, J., Tébar-Martínez, R., Gambardella, V., Martínez‐Ciarpaglini, C., García-Micó, B., Martínez-Castedo, B., Lucas, B. P.-D., García-Bartolomé, M., Seguí, V., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.102051 · Cited by 21

Urine test for EGFR analysis in patients with non-small cell lung cancer

Franovic, A., Raymond, V. M., Erlander, M. G., & Reckamp, K. L. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.06.144 · Cited by 20

Circulating Tumor DNA in KRAS positive colorectal cancer patients as a prognostic factor – a systematic review and meta-analysis

Perdyan, A., Spychalski, P., Kacperczyk, J., Rostkowska, O. M., & Kobiela, J. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103065 · Cited by 19

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer

Chibaudel, B., Henriques, J., Rakez, M., Brenner, B., Kim, T. W., Martinez–Villacampa, M., Gallego-Plazas, J., Cervantes, A. M. R., Shim, K., Jonker, D. J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.20425 · Cited by 20

ctDNA as a biomarker of progression in oesophageal adenocarcinoma

Bonazzi, V., Aoude, L. G., Brosda, S., Lonie, J. M., Patel, K., Bradford, J. J., Koufariotis, L. T., Wood, S., Smithers, B. M., Waddell, N., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100452 · Cited by 22

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

Shelton, D. N., Bhagavatula, P., Sepulveda, N., Beppu, L. W., Gandhi, S., Qin, D., Hauenstein, S. I., & Radich, J. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265278 · Cited by 20

Adjuvant Chemotherapy for Stage II Colon Cancer: The Debate Goes On

Lee, J. J., & Chu, E. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.022178 · Cited by 19

Colorectal liver metastases: state-of-the-art management and surgical approaches

Newhook, T. E., & Vauthey, J. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02496-7 · Cited by 18

Circulating tumor DNA as a prognostic indicator of colorectal cancer recurrence—a systematic review and meta-analysis

Chen, Y., Mo, S., Wu, M., Li, Y., Chen, X., & Peng, J. (2022) · International Journal of Colorectal Disease · doi:10.1007/s00384-022-04144-4 · Cited by 19

Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery

Sattar, R. S. A., Verma, R., Nimisha, Kumar, A., Dar, G. M., Apurva, A., Sharma, A. K., Kumari, I., Ahmad, E., Ali, A., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110413 · Cited by 18

Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer

Liu, J., Mroczek, M., Mach, A., Stępień, M., Aplas, A., Pronobis‐Szczylik, B., Bukowski, S., Mielczarek, M., Gajewska, E., Topolski, P., et al. (2023) · Cancers · doi:10.3390/cancers15030779 · Cited by 18

A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer

Li, M., Zhu, C., Xue, Y., Miao, C., He, R., Li, W., Zhang, B., Yu, W., Huang, X., Lv, M., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02155-8 · Cited by 18

Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing–Based Comprehensive Tumor Profiling in Liquid Biopsy Samples

Harter, J., Buth, E., Johänning, J., Battke, F., Kopp, M., Zelba, H., Schulze, M., Ködding, J., & Biskup, S. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.10.001 · Cited by 19

Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment

Yao, S., Han, Y., Yang, M., Jin, K., & Lan, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1292861 · Cited by 19

Role of circulating tumor DNA in the management of patients with colorectal cancer

Moati, É., Taly, V., Didelot, A., Perkins, G., Blons, H., Taı̈eb, J., Laurent‐Puig, P., & Zaanan, A. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.03.002 · Cited by 19

Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment

Eigėlienė, N., Saarenheimo, J., & Jekunen, A. P. (2019) · Oncology · doi:10.1159/000495615 · Cited by 19

Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs

Ma, L., Li, H., Wang, D., Hu, Y., Yu, M., Zhang, Q., Qin, N., Zhang, X., Li, X., Zhang, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643199 · Cited by 18

Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

Verbus, E. A., Rossi, A. J., Luna, A. J., Iqbal, A., Morris, V. K., & Hernandez, J. M. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10112-z · Cited by 18

Clinical Outcomes in Non–Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling

Tran, H. T., Lam, V. K. L., Elamin, Y. Y., Hong, L., Colen, R. R., Elshafeey, N. A., Hassan, I. S. A., Altan, M., Blumenschein, G. R., Rinsurongkawong, W., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00532 · Cited by 18

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer

Murphy, C., Turner, N. H., Wong, H., Sinnathamby, M., Tie, J., Lee, B., Desai, J., Skinner, I., Christie, M., Hutchinson, R. A., et al. (2016) · Internal Medicine Journal · doi:10.1111/imj.13312 · Cited by 18

Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa?

Sild, M., & Booij, L. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0366-8 · Cited by 19

Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing

Kobayashi, S., Nakamura, Y., Hashimoto, T., Bando, H., Oki, E., Karasaki, T., Horinouchi, H., Ozaki, Y., Iwata, H., Kato, T., et al. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02683-0 · Cited by 20

Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: A systematic review and network meta‐analysis

Hoang, T., Choi, M. K., Oh, J. H., & Kim, J. (2025) · International Journal of Cancer · doi:10.1002/ijc.35442 · Cited by 19

Validation of a Circulating Tumor-Derived DNA Blood Test for Detection of Methylated BCAT1 and IKZF1 DNA

Murray, D. H., Baker, R. T., Gaur, S., Young, G. P., & Pedersen, S. K. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2017.023135 · Cited by 19

The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases

Buisman, F. E., Galjart, B., van der Stok, E. P., Kemeny, N. E., Balachandran, V. P., Boerner, T., Cercek, A., Grünhagen, D. J., Jarnagin, W. R., Kingham, T. P., et al. (2019) · HPB · doi:10.1016/j.hpb.2019.11.013 · Cited by 17

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment

Ma, S., Shi, M., Chen, X., Wang, Y., Yang, Z., Lizaso, A., Li, M., Li, H., Zhang, L., Mao, X., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-371 · Cited by 17

Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR‐TKI treatment in advanced non‐small cell lung cancer

Zheng, J., Wang, Y., Hu, C., Zhu, M., Ii, J., Lin, C., Lu, C., Dou, Y., Zhao, C., Zhang, Y., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14668 · Cited by 17

Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

Hsiehchen, D., Bucheit, L. A., Yang, D., Beg, M. S., Lim, M., Lee, S. S., Kasi, P. M., Kaseb, A. O., & Zhu, H. (2022) · Nature Communications · doi:10.1038/s41467-022-35144-1 · Cited by 18

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers

Spiliopoulou, P., Vornicova, O., Genta, S., & Spreafico, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021294 · Cited by 19

Clearance Profile of Circulating Tumor Human Papillomavirus DNA During Radiotherapy Predicts Clinical Outcomes in Human Papillomavirus–Related Oropharyngeal Cancer

Tanaka, H., Uno, A., Takenaka, Y., Suzuki, M., Seo, Y., Takemoto, N., Fukusumi, T., Eguchi, H., Kanai, H., Horie, M., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00494 · Cited by 17

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer

de Abreu, A. R., de Beeck, K. O., Laurent‐Puig, P., Taly, V., & Benhaïm, L. (2023) · Cancers · doi:10.3390/cancers15041284 · Cited by 17

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers

Cha, Y., Kim, S., & Han, S. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2023.446 · Cited by 17

Potential biomarkers for immunotherapy in non-small-cell lung cancer

Wang, X., Qiao, Z.-Y., Aramini, B., Lin, D. X., Li, X., & Fan, J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10074-y · Cited by 18

Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases

Baumgartner, J. M., & Botta, G. P. (2023) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-023-00959-8 · Cited by 18

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

Douville, C. B., Curtis, S., Summers, M., Azad, T. D., Rincón-Torroella, J., Wang, Y., Mattox, A. K., Avigdor, B. E., Dudley, J. C., Materi, J. D., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101148 · Cited by 18

Circulating Tumor DNA and Management of Colorectal Cancer

Krell, M., Llera, B. G., & Brown, Z. J. (2023) · Cancers · doi:10.3390/cancers16010021 · Cited by 19

Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management

Wu, A., & Attard, G. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287250 · Cited by 18

CART manufacturing process and reasons for academy-pharma collaboration

Egri, N., de Landazuri, I. O., Bartolomé, C. S., Ortega, J. R., Español‐Rego, M., & Juan, M. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.10.014 · Cited by 18

What Is Known about Theragnostic Strategies in Colorectal Cancer

Parisi, A., Porzio, G., Pulcini, F., Cannita, K., Ficorella, C., Mattei, V., & Monache, S. D. (2021) · Biomedicines · doi:10.3390/biomedicines9020140 · Cited by 17

Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology

Earland, N. J., Chen, K., Semenkovich, N. P., Chauhan, P. S., Zevallos, J. P., & Chaudhuri, A. A. (2023) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2023.03.004 · Cited by 15

Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations

Mattox, A. K., Wang, Y., Springer, S. U., Cohen, J. D., Yegnasubramanian, S., Nelson, W. G., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701382114 · Cited by 17

Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual

Koessler, T., Addeo, A., & Nouspikel, T. P. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.12.004 · Cited by 17

Promising clinical application of ctDNA in evaluating immunotherapy efficacy.

Li, L., Zhang, J., Jiang, X., & Li, Q. (2018) · Europe PMC (PubMed Central) · Cited by 16

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer

Grancher, A., Beaussire, L., Manfrédi, S., Malicot, K. L., Dutherage, M., Verdier, V., Mulot, C., Bouché, O., Phelip, J., Levaché, C.-B., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.973167 · Cited by 16

Molecular Residual Disease-guided Adjuvant Treatment in Resected Colorectal Cancer: Focus on CIRCULATE-Japan

Sato, S., Nakamura, Y., Oki, E., & Yoshino, T. (2022) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2022.12.001 · Cited by 16

A bibliometric and scientometric: analysis towards global pattern and trends related to aerosol and precipitation studies from 2002 to 2022

Kumar, R. P., Brema, J., Samuel, C., & Gautam, S. (2022) · Air Quality Atmosphere & Health · doi:10.1007/s11869-022-01290-0 · Cited by 16

Development and Validation of Postoperative Circulating Tumor DNA Combined with Clinicopathological Risk Factors for Recurrence Prediction in Patients with Stages I-III Colorectal Cancer

Gao, Z., Huang, D., Chen, H., Yang, Y., An, K., Ding, C., Yuan, Z., Zhai, Z., Niu, P., Gao, Q., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-023-03884-3 · Cited by 18

Current and emerging applications of liquid biopsy in pan-cancer

Wang, W., He, Y., Yang, F., & Chen, K. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101720 · Cited by 17

Circadian rhythm and circulating cell-free DNA release on healthy subjects

Poulet, G., Hulot, J., Blanchard, A., Bergerot, D., Xiao, W., Ginot, F., Rodat, A., Abdelli, J., Beinse, G., Géromel, V., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47851-w · Cited by 16

Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis

O’Sullivan, N. J., Temperley, H. C., Kyle, E. T., Sweeney, K. J., O’Neill, M. A., Gillham, C., O'Sullivan, J. N., O'Kane, G. M., Mehigan, B. J., O’Toole, S. A., et al. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04656-1 · Cited by 16

Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial

Ruiz-Vico, M., Wetterskog, D., Orlando, F., Thakali, S., Wingate, A., Jayaram, A., Cremaschi, P., Vainauskas, O., Brighi, N., Castellano-Gauna, D., et al. (2024) · European Urology Oncology · doi:10.1016/j.euo.2024.08.006 · Cited by 16

Advances and challenges in the use of liquid biopsy in gynaecological oncology

Zhang, Y. X., & Tian, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39148 · Cited by 16

Precision medicine for adjuvant chemotherapy of resected colorectal cancer

Miyamoto, Y., Hiyoshi, Y., Sawayama, H., Tokunaga, R., & Baba, H. (2020) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12397 · Cited by 14

Chemo-specific designs for the enumeration of circulating tumor cells: advances in liquid biopsy

Singh, B., Arora, S., D’Souza, A., Kale, N. R., Aland, G., Bharde, A., Quadir, M., Calderón, M., Chaturvedi, P., & Khandare, J. J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02574g · Cited by 16

A Self‐Digitization Dielectrophoretic (SD‐DEP) Chip for High‐Efficiency Single‐Cell Capture, On‐Demand Compartmentalization, and Downstream Nucleic Acid Analysis

Qin, Y., Wu, L. J., Schneider, T., Yen, G. S., Wang, J., Xu, S., Li, M., Paguirigan, A. L., Smith, J. L., Radich, J. P., et al. (2018) · Angewandte Chemie · doi:10.1002/ange.201807314 · Cited by 16

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer

Dérangère, V., Lecuelle, J., Lepage, C., Salem, O. A.-B., Allatessem, B. M., Ilie, A., Bouché, O., Phelip, J., Baconnier, M., Pezet, D., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.05.040 · Cited by 16

Prognostic potential of circulating tumor DNA detection at different time periods in resectable non-small cell lung cancer: Evidence from a meta-analysis

Wang, B., Pei, J., Wang, S., Cheng, K. D., Yu, J., & Liu, J. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103771 · Cited by 16

Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients

Henriksen, T. V., Reinert, T., Rasmussen, M. H., Demuth, C., Løve, U. S., Madsen, A. H., Gotschalck, K. A., Iversen, L. H., & Andersen, C. L. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13294 · Cited by 16

Cell-Free DNA Diagnostics: Current and Emerging Applications in Oncology

Muluhngwi, P., Valdes, R., Fernandez-Botrán, R., Burton, E., Williams, B. J., & Linder, M. W. (2019) · Pharmacogenomics · doi:10.2217/pgs-2018-0174 · Cited by 16

The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy

Low, S., & Nakamura, Y. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz073 · Cited by 16

Chemical tools for discriminating single nucleotide variants: from design principles to clinical applications

Huang, D., Liu, Y., Wang, G. A., Lv, S., Tan, Y., & Li, F. (2025) · Chemical Society Reviews · doi:10.1039/d5cs01006c · Cited by 17

Detection of minimal residual disease by circulating tumour DNA and risk of recurrence in Stage I–III colorectal cancer: the CITCCA study

Merk, C., Birkeälv, S., Strandberg, R., Bergström, R., Putcha, G. V., Mayrhofer, M., Howarth, K., Lindberg, J., & Martling, A. (2026) · British journal of surgery · doi:10.1093/bjs/znag093.030

Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy, and identify patients at high risk of recurrence in patients with stage I-III CRC.

Tarazona, N., Henriksen, T. V., Carbonell‐Asins, J. A., Reinert, T., Sharma, S., Roda, D., Shchegrova, S., Huerta, M., Roselló, S., Renner, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.4009 · Cited by 19

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

Tie, J., Kinde, I., Wang, Y., Wong, H., Skinner, I., Wong, R., Steel, M., Diaz, L. A., Papadopoulos, N., Kosmider, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.11015 · Cited by 19

Postoperative circulating tumor DNA in stage II colon cancer: biological rationale, clinical evidence, and unresolved challenges

Yang, E., Wang, X., Zhang, J., Zhao, D., Yang, Z., Li, X., He, G., Guo, T., Wang, R., & Yuan, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1908802

Use of circulating tumor DNA analysis to predict recurrence and need for adjuvant chemotherapy in stage I-IV colorectal cancer.

Li, L., Fan, W., Xia, Z., Chen, R., Lin, D., Li, F., Zheng, Y., Luo, J., Xiong, Y., Yu, P., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.2023.41.16_suppl.e15537